
The UK Supreme Court has sent shockwaves through the intellectual property world with its recent decision on Eli Lilly v …
The National Institute for Health and Care Excellence (NICE) has issued its approval of two drugs for routine use on …

Eli Lilly says it plans to appeal a UK High Court’s verdict that could imminently open its blockbuster lung cancer …

A German court has ruled that Lilly’s patent for its lung cancer drug Alimta would not be infringed by generic …

Eli Lilly is coming to terms with rejection by NICE after the cost watchdog said it would not recommend Alimta …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

